NanoZymeX secures €160K to advance lipid nanoparticle enzyme therapies for rare diseases

Biotech startup NanoZymeX has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles. Spun out of research at the Univers…

Rivia raises $15M to fix the broken data infrastructure behind clinical trials

Rivia, the Zurich-based data engine for clinical trial intelligence, today announced a $15 million Series A led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino …

Decoding DNA with AI: Living Models emerges from stealth with $7M

Living Models, a Paris–Berkeleystartup, has raised $7 million in seed funding as it emerges from stealth todevelop foundation models for biology trained on DNA, RNA, and multi-omics dataaimed at impro…

Cytotrait raises £3M for agricultural gene-editing technology

Cytotrait, aspinout from The University of Manchester focused on developing new traits forfood and agricultural applications, has closed a £3 million seed funding round.The round was led by Northern G…

University of Edinburgh biotech spin-out BIOCAPTIVA raises £1.58M

University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US. BIOCAPTIVA’s novel magnetic bead technology is designed to solve o…

Wilbe opens White City lab in London to remove infrastructure bottlenecks for science startups

Wilbe, the venture fund and platform that trains and backs scientists to build companies from day one, today announces the launch of its first dedicated lab facility in White City, London.To date, Wil…

Shellworks raises $15M to scale sustainable plastic alternative Vivomer

London-basedbiomaterials company Shellworks has raised $15 million in a Series A fundinground led by Paris-based impact investment fund alter equity. The round alsoincluded participation from Nat Frie…

Antiverse secures $9.3M Series A for AI antibody platform

UK-based Antiverse, abiotech company developing AI-designed therapeutic antibodies forhard-to-target disease targets, has closed a $9.3 million Series A round led bySoulmates Ventures, with participat…

Outpost Bio raises $3.5M pre-seed for human microbiology models

Outpost Bio, a companyfocused on decoding complex interactions in human biology, has raised a $3.5million pre-seed round co-led by Merantix Capital and Seedcamp, withparticipation from OpenSeed VC, De…

Can Everdye clean up one of fashion’s dirtiest processes?
Can Everdye clean up one of fashion’s dirtiest processes?

Behind every brightly coloured garment lies a largely invisible cost. Dyeing synthetic fibres can account for up to 60 per cent of the total energy used in textile production, while the global dyeing …